Mapping the Theories of Preeclampsia: The Role of Homocysteine

OBJECTIVE: We conducted a systematic review to examine the hypothesized mechanism through which homocysteine could lead to preeclampsia. DATA SOURCES: We searched MEDLINE, EMBASE, BIOSIS, SciSearch, and bibliographies of primary and review articles, and we contacted experts. METHODS OF STUDY SELECTION: Of the 25 relevant primary articles, 8 studies measured total serum homocysteine concentrations before the clinical onset of preeclampsia (1,876 women), whereas 17 measured it afterward (1,773 women). Meta-analytic techniques were used to examine consistency, strength, temporality, dose-response, and plausibility of the disease mechanisms implicating folate, vitamin B6, vitamin B12, genetic polymorphisms, oxidative stress, and endothelial dysfunction in the pathway linking hyperhomocysteinemia to preeclampsia. TABULATION, INTEGRATION, AND RESULTS: Overall, there were higher serum homocysteine concentrations among pregnant women with preeclampsia than among those with uncomplicated pregnancies, but the results were heterogeneous (P = .12; I2 = 38.8%). Among studies with temporality, the size of association was smaller than that among those without (weighted mean difference 0.68 &mgr;mol/L versus 3.36 &mgr;mol/L; P < .006). There was no dose-response relationship between homocysteine concentration and severity of preeclampsia. The mechanisms underlying hyperhomocysteinemia (folate and vitamin B12 deficiency and genetic polymorphisms) were not found to be plausible, but markers of oxidative stress and endothelial dysfunction were higher in hyperhomocysteinemia. CONCLUSION: Homocysteine concentrations are slightly increased in normotensive pregnancies that later develop preeclampsia and are considerably increased once preeclampsia is established. However, because of a lack of consistency in data, dose-response relationship, and biologic plausibility, the observed association cannot be considered causal from the current literature.

[1]  Julian P T Higgins,et al.  Controlling the risk of spurious findings from meta‐regression , 2004, Statistics in medicine.

[2]  P. Sandercock,et al.  Where is the evidence that animal research benefits humans? , 2004, BMJ : British Medical Journal.

[3]  R. Ientile,et al.  Plasma homocysteine in early and late pregnancies complicated with preeclampsia and isolated intrauterine growth restriction , 2004, Acta obstetricia et gynecologica Scandinavica.

[4]  K. Conrad,et al.  Renal Handling of Homocysteine During Normal Pregnancy and Preeclampsia , 2004, The Journal of the Society for Gynecologic Investigation: JSGI.

[5]  H. Celik,et al.  The correlation between plasma homocysteine and malondialdehyde levels in preeclampsia. , 2003, Neuro endocrinology letters.

[6]  E. Onur,et al.  Endothelial Dysfunction in Preeclampsia , 2003, Gynecologic and Obstetric Investigation.

[7]  P. A. van den Brandt,et al.  Energy restriction and the risk of spontaneous mammary tumors in mice: A meta‐analysis , 2003, International journal of cancer.

[8]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[9]  S. Devaraj,et al.  Homocysteine plasma concentration levels for the prediction of preeclampsia in women with chronic hypertension. , 2003, American journal of obstetrics and gynecology.

[10]  S. Daly,et al.  Elevated plasma homocysteine in early pregnancy: a risk factor for the development of nonsevere preeclampsia. , 2003, American journal of obstetrics and gynecology.

[11]  Raeburn Forbes,et al.  Systematic Reviews to Support Evidence-based Medicine , 2003, The Ulster Medical Journal.

[12]  M. Volmer,et al.  Fasting vs nonfasting plasma homocysteine concentrations for diagnosis of hyperhomocysteinemia. , 2003, Clinical chemistry.

[13]  M. Vilaseca,et al.  Plasma total homocysteine in uncomplicated pregnancy and in preeclampsia. , 2003, European journal of obstetrics, gynecology, and reproductive biology.

[14]  M. Dunbar,et al.  The 677 C‐T Methylenetetrahydrofolate Reductase Mutation Does Not Predict Increased Maternal Homocysteine During Pregnancy , 2003, Obstetrics and gynecology.

[15]  B. Bowman,et al.  Laboratory issues: use of nutritional biomarkers. , 2003, The Journal of nutrition.

[16]  R. Collins,et al.  Stabilization of homocysteine in unseparated blood over several days: a solution for epidemiological studies. , 2003, Clinical chemistry.

[17]  J. Cutler,et al.  Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy , 2003, Hypertension in pregnancy.

[18]  J. Eckfeldt,et al.  Interlaboratory variation of plasma total homocysteine measurements: results of three successive homocysteine proficiency testing surveys. , 2002, Clinical chemistry.

[19]  J. Granger,et al.  Pathophysiology of Preeclampsia: Linking Placental Ischemia/Hypoxia with Microvascular Dysfunction , 2002, Microcirculation.

[20]  Irene Kwan,et al.  Does animal experimentation inform human healthcare? Observations from a systematic review of international animal experiments on fluid resuscitation , 2002, BMJ : British Medical Journal.

[21]  A Donner,et al.  Meta‐analyses in systematic reviews of randomized controlled trials in perinatal medicine: comparison of fixed and random effects models , 2001, Statistics in medicine.

[22]  T. Kubo,et al.  The Relation between Plasma Homocysteine Concentration and Methylenetetrahydrofolate Reductase Gene Polymorphism in Pregnant Women , 2001, The journal of obstetrics and gynaecology research.

[23]  M. Limburg,et al.  Nimodipine in Animal Model Experiments of Focal Cerebral Ischemia: A Systematic Review , 2001, Stroke.

[24]  M. Medina,et al.  Roles of homocysteine in cell metabolism: old and new functions. , 2001, European journal of biochemistry.

[25]  Jonathan A C Sterne,et al.  Systematic reviews in health care: Investigating and dealing with publication and other biases in meta-analysis. , 2001, BMJ.

[26]  E. Steegers,et al.  Hyperhomocysteinaemia: a risk factor for preeclampsia? , 2001, European journal of obstetrics, gynecology, and reproductive biology.

[27]  U. Turpeinen,et al.  Serum Homocysteine at 16 Weeks and Subsequent Preeclampsia , 2001, Obstetrics and gynecology.

[28]  P. Ueland,et al.  Plasma Total Homocysteine Is Influenced by Prandial Status in Humans: The Hordaland Homocysteine Study 1 , 2001 .

[29]  Cuilin Zhang,et al.  Plasma folate, vitamin B(12), and homocyst(e)ine concentrations in preeclamptic and normotensive Peruvian women. , 2001, American journal of epidemiology.

[30]  E. Steegers,et al.  Oxidized and Free Whole Blood Thiols in Preeclampsia , 2001, Obstetrics and gynecology.

[31]  Y. Aubard,et al.  Hyperhomocysteinemia and pregnancy--review of our present understanding and therapeutic implications. , 2000, European journal of obstetrics, gynecology, and reproductive biology.

[32]  W. Sibbald.  An alternative pathway for preclinical research in fluid management , 2000, Critical care.

[33]  R. Goldenberg,et al.  Second-trimester plasma homocysteine levels and pregnancy-induced hypertension, preeclampsia, and intrauterine growth restriction. , 2000, American journal of obstetrics and gynecology.

[34]  Anne-Lise Bjørke Monsen,et al.  Plasma total homocysteine, pregnancy complications, and adverse pregnancy outcomes: the Hordaland Homocysteine study. , 2000, The American journal of clinical nutrition.

[35]  Xing Li Wang,et al.  Elevated circulating homocyst(e)ine levels in placental vascular disease and associated pre‐eclampsia , 2000, BJOG : an international journal of obstetrics and gynaecology.

[36]  D. Weed,et al.  Interpreting epidemiological evidence: how meta-analysis and causal inference methods are related. , 2000, International journal of epidemiology.

[37]  I. Olkin,et al.  Meta-analysis of observational studies in epidemiology - A proposal for reporting , 2000 .

[38]  M. Picciano.  Is homocysteine a biomarker for identifying women at risk of complications and adverse pregnancy outcomes? , 2000, The American journal of clinical nutrition.

[39]  A. Kaider,et al.  Serum homocyst(e)ine levels in women with preeclampsia. , 2000, Wiener klinische Wochenschrift.

[40]  A. Hart,et al.  Medical statistics − a commonsense approach , 2000, Postgraduate medical journal.

[41]  P. Zusterzeel,et al.  Plasma Thiol Status in Preeclampsia , 2000, Obstetrics and gynecology.

[42]  M. Medina,et al.  Methods for the Determination of Plasma Total Homocysteine: a Review , 2000, Clinical chemistry and laboratory medicine.

[43]  J. Kooner,et al.  Physiological increments in plasma homocysteine induce vascular endothelial dysfunction in normal human subjects. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[44]  M. Faas,et al.  Etiology and pathogenesis of preeclampsia: current concepts. , 1999, American journal of obstetrics and gynecology.

[45]  A. Rajkovic,et al.  Plasma homocyst(e)ine concentrations in eclamptic and preeclamptic African women postpartum. , 1999, Obstetrics and gynecology.

[46]  C. Laskin,et al.  Folic acid and homocyst(e)ine metabolic defects and the risk of placental abruption, pre-eclampsia and spontaneous pregnancy loss: A systematic review. , 1999, Placenta.

[47]  E. Gunter,et al.  Comparison of plasma total homocysteine measurements in 14 laboratories: an international study. , 1999, Clinical chemistry.

[48]  D. Luthy,et al.  Elevated Second-Trimester Serum Homocyst(e)ine Levels and Subsequent Risk of Preeclampsia , 1999, Gynecologic and Obstetric Investigation.

[49]  G. Hankey,et al.  Homocysteine and vascular disease , 1999, The Lancet.

[50]  A R Feinstein,et al.  Clinical epidemiological quality in molecular genetic research: the need for methodological standards. , 1999, JAMA.

[51]  H. Laivuori,et al.  Plasma homocysteine levels elevated and inversely related to insulin sensitivity in preeclampsia. , 1999, Obstetrics and gynecology.

[52]  A. Many,et al.  Increased frequency of genetic thrombophilia in women with complications of pregnancy. , 1999, The New England journal of medicine.

[53]  R. Ness,et al.  Plasma homocysteine concentration is increased in preeclampsia and is associated with evidence of endothelial activation. , 1998, American journal of obstetrics and gynecology.

[54]  M. Stanton,et al.  Homocysteine and cardiovascular disease , 2011 .

[55]  J. D. Vries,et al.  Effects of folic acid and vitamin B6 supplementation on women with hyperhomocysteinemia and a history of preeclampsia or fetal growth restriction. , 1998, American journal of obstetrics and gynecology.

[56]  D. Weed,et al.  Biologic plausibility in causal inference: current method and practice. , 1998, American journal of epidemiology.

[57]  S. Tyagi.  Homocysteine redox receptor and regulation of extracellular matrix components in vascular cells. , 1998, American journal of physiology. Cell physiology.

[58]  D. Weed,et al.  On the use of causal criteria. , 1997, International journal of epidemiology.

[59]  A. Rajkovic,et al.  Elevated Homocyst(e)ine Levels With Preeclampsia , 1997, Obstetrics and gynecology.

[60]  J. Loscalzo.  The oxidant stress of hyperhomocyst(e)inemia. , 1996, The Journal of clinical investigation.

[61]  J. D. Vries,et al.  Underlying disorders associated with severe early-onset preeclampsia. , 1995, American journal of obstetrics and gynecology.

[62]  H. Blom,et al.  Lipid peroxidation and susceptibility of low‐density lipoprotein to in vitro oxidation in hyperhomocysteinaemia , 1995, European journal of clinical investigation.

[63]  P. Ueland,et al.  Methionine synthase inactivation by nitrous oxide during methionine loading of normal human fibroblasts. Homocysteine remethylation as determinant of enzyme inactivation and homocysteine export. , 1993, The Journal of pharmacology and experimental therapeutics.

[64]  B. Hultberg,et al.  Homocysteine export from erythrocytes and its implication for plasma sampling. , 1992, Clinical chemistry.

[65]  J. Roberts,et al.  Clinical and biochemical evidence of endothelial cell dysfunction in the pregnancy syndrome preeclampsia. , 1991, American journal of hypertension.

[66]  J. Wittes,et al.  Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials. , 1991, JAMA.

[67]  T. Musci,et al.  Preeclampsia: an endothelial cell disorder. , 1989, American journal of obstetrics and gynecology.

[68]  N. Breslow,et al.  Statistical methods in cancer research: volume 1- The analysis of case-control studies , 1980 .

[69]  A. B. Hill.  The Environment and Disease: Association or Causation? , 1965, Proceedings of the Royal Society of Medicine.

[70]  M. Kenward,et al.  An Introduction to the Bootstrap , 2007 .

[71]  I. Greer,et al.  Effect of supplementation with folic acid throughout pregnancy on plasma homocysteine concentration. , 2004, Thrombosis research.

[72]  E. Onur,et al.  Endothelial dysfunction in preeclampsia. Increased homocysteine and decreased nitric oxide levels. , 2003, Gynecologic and obstetric investigation.

[73]  R. D. de Haan,et al.  Wound Healing in Cell Studies and Animal Model Experiments by Low Level Laser Therapy; Were Clinical Studies Justified? A Systematic Review , 2002, Lasers in Medical Science.

[74]  R. Ness,et al.  Homocysteine and cellular fibronectin are increased in preeclampsia, not transient hypertension of pregnancy. , 2001, Hypertension in pregnancy.

[75]  L. E. Martínez de Villarreal,et al.  [Folic acid levels, homocysteine and polymorphism of methylenetetrahydrofolate reductase enzyme (MTHFR) in patients with pre-eclampsia and eclampsia]. , 2001, Ginecologia y obstetricia de Mexico.

[76]  S. Daly,et al.  Elevated plasma homocysteine in early pregnancy: a risk factor for the development of severe preeclampsia. , 2001, American journal of obstetrics and gynecology.

[77]  J. Ubbink.  Assay Methods for the Measurement of Total Homocyst(e)ine in Plasma , 2000, Seminars in thrombosis and hemostasis.

[78]  M. De Falco,et al.  Homocysteinaemia during pregnancy and placental disease. , 2000, Clinical and experimental obstetrics & gynecology.

[79]  M. Vilaseca,et al.  [Homocysteine and pregnancy]. , 2000, Medicina clinica.

[80]  Assessment of laboratory tests for plasma homocysteine--selected laboratories, July-September 1998. , 1999, MMWR. Morbidity and mortality weekly report.

[81]  B. Vester,et al.  High Performance Liquid Chromatography Method for Rapid and Accurate Determination of Homocysteine in Plasma and Serum , 1991, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.